• Gynecological Trials

    Gynecological Trials

    Here you find the current Swiss-GO trials.

Clinical Trials

Swiss-GO is here for you and your patient!

For evaluation and support for your research projects in the field of gynecological oncology and the coordination and implementation of your studies.

Expression VI (Carolin meets HANNA) Long-Term Survivors

Expression VI (Carolin meets HANNA) Long-Term Survivors

In Switzerland, every year, approximately 800 women are diagnosed with ovarian, fallopian tube or peritoneal cancer. (Filler800 women are diagnosed with ovarian, fallopian tube or peritoneal)

More Info

MATAO newly diagnosed Ovarian Cancer

MATAO newly diagnosed Ovarian Cancer

MATAO - A clinical phase III trial on the use of letrozole maintenance therapy for newly diagnosed advanced ovarian, fallopian tube or peritoneal cancers. (varian, fallopian tube or peritoneal cancers)

More Info

The IRMA Study

The IRMA Study

The IRMA Study is a multicenter observational cohort study of women undergoing immediate breast reconstruction following either prophylactic mastectomy or mastectomy due to breast cancer.

More Info

BOUQUET Trial: Rare Ovarian cancers

BOUQUET Trial: Rare Ovarian cancers

This study will evaluate the efficacy and safety of multiple biomarker-selected treatments in patients with persistent or recurrent rare epithelial ovarian, fallopian tube, or primary peritoneal tumors

Address

Swiss GO Trial Group
Gynecological Oncology
Hospital for Women
University Hospital Basel
Spitalstrasse 21
CH-4031 Basel
Switzerland

Contact Info

Phone: +41 61 265 75 00
Fax:      +41 61 265 93 22

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Swiss GO Logo
© Swiss GO Trial Group, Basel